Sign Out
Gastrointestinal disorders: upper abdominal pain, diarrhea, constipation, flatulence, nausea/vomiting, dry mouth.
General disorders and administration site conditions: injection site thrombophlebitis, peripheral edema.
Hepatobiliary disorders: severe hepatocellular damage leading to jaundice with or without hepatic failure.
Immune system disorders: anaphylactic reactions including anaphylactic shock.
Investigations: increased liver enzymes (transaminase, γ-GT), elevated triglycerides, increased body temperature.
Musculoskeletal, connective tissue disorders: arthralgia, myalgia.
Nervous system disorders: headache, dizziness, disturbances in vision (blurred vision).
Psychiatric disorders: mental depression.
Renal and urinary disorders: interstitial nephritis.
Skin and subcutaneous tissue disorders: allergic reactions such as pruritus and skin rash, urticaria, angioedema, severe skin reaction such as Stevens-Johnson syndrome, erythema multiforme, Lyell syndrome, photosensitivity.
View ADR Monitoring Form
